CurrentCardio
Get Weekly

Topic · page 19 of 34

Arrhythmias & electrophysiology

AF (incl. stroke prevention and anticoagulation in AF), ventricular arrhythmias, sudden death prevention, pacing and conduction, ablation, syncope

Briefs 721–760 of 1,350 placed here, newest publication first

Briefs in Arrhythmias & electrophysiology

Newest publication first

  1. Eur J Prev Cardiol

    Psychiatric disorders and the risk of atrial fibrillation: a Swedish population-based cohort study

    Cohort study

  2. Europace

    Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference

    Guideline or statement

  3. Europace

    Cardiac implantable electronic device upgrades and downgrades: a Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Asia Pacific Heart Rhythm Association (APHRS), Canadian Heart Rhythm Society (CHRS), Heart Rhythm Society (HRS), and the Latin American Heart Rhythm Society (LAHRS)

    Guideline or statement

  4. Europace

    Outcomes for patients implanted with a cardioverter-defibrillator at <19 years of age: a Swedish national study

    Cohort study

  5. Europace

    Risk of cancer following presentation with new-onset atrial fibrillation using data from UK national databases

    Diagnostic or prognostic study

  6. J Am Coll Cardiol

    Pulsed Field Ablation Using a Novel Biphasic Catheter vs Thermal Ablation for Paroxysmal Atrial Fibrillation: InsightPFA Trial

    Randomised controlled trial

  7. Europace

    Pre-procedural computed tomography predicts procedural complexity and complications in bidirectional rotational mechanical transvenous lead extraction

    Cohort study

  8. Circulation

    Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome

    Cohort study

  9. JACC Cardiovasc Imaging

    Right Ventricular Outflow Tract Diameter for Event Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: Incremental Value Over Echocardiographic Free-Wall Strain

    Cross-sectional study

  10. JAMA Cardiol

    Adverse Pregnancy Outcomes and Long-Term Risk of Atrial Fibrillation

    Cohort study

  11. JAMA Cardiol

    Aggressive Risk Factor Reduction Study for Atrial Fibrillation Implications for Ablation Outcomes: The ARREST-AF Randomized Clinical Trial

    Randomised controlled trial

  12. JAMA Cardiol

    Contributions of Common, Rare, and Somatic Genetic Variants to Incidence of Atrial Fibrillation

    Cohort study

  13. JAMA Cardiol

    Intracardiac vs Transesophageal Echocardiography in Atrial Fibrillation Ablation: A Randomized Clinical Trial

    Randomised controlled trial

  14. JAMA Cardiol

    Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical Trial

    Secondary analysis

  15. Europace

    Catheter ablation vs. anti-arrhythmic drug therapy for ventricular tachycardia in ischaemic heart disease: a meta-analysis of randomized controlled trials

    Meta-analysis

  16. Europace

    Left ventricular ejection fraction and myocardial fibrosis in sudden cardiac death

    Cohort study

  17. Europace

    Women with persistent atrial fibrillation need more than pulmonary vein isolation: personalised extra-pulmonary vein ablation strategy vs. pulmonary vein isolation alone in the TAILORED-AF trial

    Secondary analysis

  18. Eur J Prev Cardiol

    Life-course exposure to PM2.5 components and genetic susceptibility on the risk of atrial fibrillation and subsequent heart failure

    Cohort study

  19. J Am Coll Cardiol

    HRS/ACC Scientific Statement: Guiding Principles on the Performance of Intracardiac Ablation Procedures in Ambulatory Surgical Centers

    Guideline or statement

  20. Circulation

    Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade

    Cohort study

  21. Eur Heart J

    Temporal trends in the use of oral anticoagulants and clinical outcomes in older, elderly, and very elderly patients with atrial fibrillation: a Danish nationwide study

    Cohort study

  22. Europace

    Characterization of sedation strategies in real-world use of pulsed field ablation Sub-analysis of the EU-PORIA registry

    Secondary analysis

  23. Europace

    Procedural characteristics and clinical outcomes from same-day discharge after pulsed field ablation treatment for atrial fibrillation: an admIRE trial sub-analysis

    Secondary analysis

  24. BMJ

    Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial

    Randomised controlled trial

  25. Europace

    Micra leadless pacemaker revisions: incidence, characteristics, and outcomes from a multicentre French cohort

    Cohort study

  26. J Am Coll Cardiol

    Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US

    Cohort study

  27. Europace

    Association between comorbidity burden and outcomes of catheter ablation vs. medical therapy for atrial fibrillation: insights from the CABANA trial

    Secondary analysis

  28. Europace

    Wearable smartwatches for atrial fibrillation detection and burden estimation after ablation: comparison with continuous monitoring

    Secondary analysis

  29. Circulation

    Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial

    Randomised controlled trial

  30. N Engl J Med

    Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents

    Randomised controlled trial

  31. Circulation

    Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation

    Diagnostic or prognostic study

  32. N Engl J Med

    Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation

    Randomised controlled trial

  33. Europace

    Familial risk of Wolff–Parkinson–White syndrome: a nationwide family study in Sweden

    Cohort study

  34. Europace

    Sarcopenia in atrial fibrillation: a risk factor for adverse outcomes in a UK Biobank study

    Cohort study

  35. Europace

    Prediction of ventricular arrhythmias and sudden cardiac death by quantification and location of late gadolinium enhancement on cardiac magnetic resonance: a systematic review and meta-analysis

    Meta-analysis

  36. Europace

    Calmodulinopathies: the need for a registry

    Guideline or statement

  37. JAMA Cardiol

    Artificial Intelligence–Enhanced Electrocardiography for Complete Heart Block Risk Stratification

    Diagnostic or prognostic study

  38. JAMA Cardiol

    Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial

    Secondary analysis

  39. Eur Heart J

    Genetic evaluation of early-onset atrial fibrillation: impact on patient management

    Cohort study

  40. J Am Coll Cardiol

    Atrial Fibrillation Screening According to Genetic Risk: A Secondary Analysis of the Randomized LOOP Study

    Secondary analysis

All 1,350 Briefs in ExploreShowing Briefs 721–760 of 1,350, newest first